Anti-estrogen combo better than single drug for hormone-sensitive breast cancer
Wednesday, December 7, 2011 - 10:31
in Health & Medicine
Post-menopausal women with hormone receptor-positive metastatic breast cancer may have a new treatment option that could lengthen their lives, according to results of a study by the SWOG clinical trials network that were presented at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium.